abstract |
The present invention relates to a pharmaceutical composition comprising a selective imidazoline receptor agonist in combination with an angiotensin II receptor blocker. In particular, the present invention relates to pharmaceutical compositions comprising moxonidine and eprosartan mesylate. The present invention also relates to the use of the composition in the manufacture of a medicament for the treatment of hypertensive patients who are already suffering from, or likely to develop, type II diabetes. |